₹1,117.55
+37.35 (+3.46%)
As of 18 Sept 2026, Windlas Biotech Ltd share price is ₹1,117.55. The stock opened at ₹1,117.55 and had closed at ₹1,080.20 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹699.35 and a high of ₹1,181.00. In terms of performance, Windlas Biotech Ltd share price has increased by 47.52% over the past six months and has increased by 12.19% over the last year.
WINDLAS Stock Price Chart
Windlas Biotech Ltd Overview
Market cap₹2,306 Crs
Volume6,465
Prev. Close₹1,080.20
Year range₹699.35 - ₹1,181.00
ISININE0H5O01029
About WINDLAS
Windlas Biotech engaged in manufacturing and trading of pharmaceutical products.
Windlas Biotech Ltd Historical Performance
1 Month Return15.60%
6 Month Return52.46%
3 Year Return194.37%
3 Month Return30.81%
1 Year Return7.79%
5 Year Return187.78%
Windlas Biotech Ltd Fundamentals
ROCE(TTM)14.89%
P/E Ratio (TTM)33.56
P/B Ratio3.84
Debt to Equity0.06
ROE11.44%
EPS (TTM)32.19
Dividend Yield0.58%
Book Value281.35
Profit Margin7.05%
Operating Margin7.89%
Windlas Biotech Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 921.89 | 777.53 | 644.43 | 523.05 | 472.64 |
| EBITDA | 122.50 | 111.76 | 91.56 | 70.21 | 59.61 |
| Net Profit | 66.44 | 60.65 | 58.14 | 42.64 | 38.56 |
| EPS | 31.59 | 29.03 | 27.95 | 19.71 | 18.81 |
Windlas Biotech Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 1,056.40 |
| Resistance 1 (R1) | 1,101.45 |
| Pivot Point | 1,077.65 |
Windlas Biotech Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 16-Jul-2026 | 21-May-2026 | 16-Jul-2026 | Final | ₹6.30 |
| 21-Jul-2025 | 22-May-2025 | 21-Jul-2025 | Final | ₹5.80 |
| 17-Sep-2024 | 20-May-2024 | 17-Sep-2024 | Final | ₹5.50 |
| 05-Sep-2023 | 05-May-2023 | 05-Sep-2023 | Final | ₹4.00 |
| 09-Sep-2022 | 12-May-2022 | 12-Sep-2022 | Final | ₹3.50 |
WINDLAS Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Vivek Dhariwal | Chairman |
| ASHOK KUMAR WINDLASS | WTD & Executive Directorector |
| MANOJ KUMAR WINDLASS | Managing Director |
Windlas Biotech Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,867.30+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,323.00+1.80% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,875.00+1.30% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Windlas Biotech Ltd today is ₹1,117.55 on NSE and ₹1,117.55 on BSE.
- The 52-week high of Windlas Biotech Ltd is ₹1,181.00, while the 52-week low is ₹699.35.
- The current market capitalisation of Windlas Biotech Ltd is approximately ₹2,306 crore.
- The P/E (Price-to-Earnings) ratio of Windlas Biotech Ltd is 23.95. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Windlas Biotech Ltd is 2.99. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Windlas Biotech Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for WINDLAS on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Windlas Biotech Ltd has delivered a return of approximately 194.37%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Windlas Biotech Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 63.31% promoters, -3.71% FIIs, 9.84% DIIs, and 20.44% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
